LNZ101 (Aceclidine /Brimonidine) ophthalmic solution
JX07002
Phase 1 small_molecule completed
Quick answer
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution for Presbyopia is a Phase 1 program (small_molecule) at LENZ Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LENZ Therapeutics
- Indication
- Presbyopia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed